16-76: Assessing the value of novel biomarkers in the prediction of clinical outcomes after cardiac resynchronization therapy

MLA

Levente Molnár, et al. “16-76: Assessing the Value of Novel Biomarkers in the Prediction of Clinical Outcomes after Cardiac Resynchronization Therapy.” EP Europace, vol. 18, June 2016, p. i19. EBSCOhost, https://doi.org/10.1093/europace/18.suppl_1.i19c.

APA

Levente Molnár, Gábor Széplaki, András Mihály Boros, Endre Zima, Béla Merkely, Péter Perge, László Gellér, Szabolcs Szilágyi, István Osztheimer, & Eva Forizs. (2016). 16-76: Assessing the value of novel biomarkers in the prediction of clinical outcomes after cardiac resynchronization therapy. EP Europace, 18, i19. https://doi.org/10.1093/europace/18.suppl_1.i19c

Chicago

Levente Molnár, Gábor Széplaki, András Mihály Boros, Endre Zima, Béla Merkely, Péter Perge, László Gellér, Szabolcs Szilágyi, István Osztheimer, and Eva Forizs. 2016. “16-76: Assessing the Value of Novel Biomarkers in the Prediction of Clinical Outcomes after Cardiac Resynchronization Therapy.” EP Europace 18 (June): i19. doi:10.1093/europace/18.suppl_1.i19c.